GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 2 filers reported holding GENMAB A/S in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,407 | +29.8% | 1,174,000 | +39.9% | 0.07% | +54.3% |
Q2 2023 | $31,894 | -19.5% | 839,100 | -20.1% | 0.05% | -13.2% |
Q1 2023 | $39,633 | -21.5% | 1,049,600 | -11.9% | 0.05% | -23.2% |
Q4 2022 | $50,462 | -99.8% | 1,190,700 | +29.9% | 0.07% | +64.3% |
Q3 2022 | $29,444,000 | -7.5% | 916,400 | -6.5% | 0.04% | +10.5% |
Q2 2022 | $31,847,000 | -19.1% | 980,200 | -9.9% | 0.04% | -17.4% |
Q1 2022 | $39,382,000 | -7.3% | 1,088,500 | +1.3% | 0.05% | -13.2% |
Q4 2021 | $42,503,000 | +8.2% | 1,074,400 | +19.5% | 0.05% | +3.9% |
Q3 2021 | $39,278,000 | +8.7% | 898,800 | +1.6% | 0.05% | +13.3% |
Q2 2021 | $36,130,000 | +10.9% | 884,900 | -10.8% | 0.04% | +9.8% |
Q1 2021 | $32,577,000 | -38.9% | 992,300 | -24.3% | 0.04% | -29.3% |
Q4 2020 | $53,313,000 | -12.4% | 1,311,200 | -21.2% | 0.06% | -4.9% |
Q3 2020 | $60,890,000 | +62.9% | 1,663,200 | +50.8% | 0.06% | +90.6% |
Q2 2020 | $37,384,000 | +1088.7% | 1,103,097 | +643.3% | 0.03% | +966.7% |
Q1 2020 | $3,145,000 | – | 148,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 242,848 | $10,291,898 | 3.87% |
Arlington Capital Management, Inc. | 26,115 | $1,106,754 | 1.24% |
Dorsey Wright & Associates | 87,451 | $3,706,173 | 1.08% |
Hardman Johnston Global Advisors LLC | 604,982 | $25,639,137 | 1.00% |
TORRAY INVESTMENT PARTNERS LLC | 128,564 | $5,448,542 | 0.98% |
Yorktown Management & Research Co Inc | 16,600 | $703,508 | 0.86% |
First Light Asset Management, LLC | 160,263 | $6,791,946 | 0.63% |
KLR INVESTMENT ADVISORS, LLC | 12,604 | $534,158 | 0.44% |
Campbell & CO Investment Adviser LLC | 42,851 | $1,816,025 | 0.43% |
Integrated Investment Consultants, LLC | 15,946 | $675,791 | 0.23% |